Literature DB >> 22462703

Intractable episodic bradycardia resulting from progressive lead traction in an epileptic child with a vagus nerve stimulator: a delayed complication.

Aaron J Clark1, Rachel A Kuperman, Kurtis I Auguste, Peter P Sun.   

Abstract

Vagus nerve stimulation (VNS) is used as palliation for adult and pediatric patients with intractable epilepsy who are not candidates for curative resection. Although the treatment is generally safe, complications can occur intraoperatively, perioperatively, and in a delayed time frame. In the literature, there are 2 reports of pediatric patients with implanted VNS units who had refractory bradycardia that resolved after the stimulation was turned off. The authors report the case of a 13-year-old boy with a history of vagus nerve stimulator placement at 2 years of age, who developed intractable episodic bradycardia that persisted despite the cessation of VNS and whose imaging results suggested vagus nerve tethering by the leads. He was subsequently taken to the operating room for exploration, where it was confirmed that the stimulator lead was exerting traction on the vagus nerve, which was displaced from the carotid sheath. After the vagus nerve was untethered and the leads were replaced, the bradycardia eventually resolved with continual effective VNS therapy. When placing a VNS unit in a very young child, accommodations must be made for years of expected growth. Delayed intractable bradycardia can result from a vagus nerve under traction by tethered stimulator leads.

Entities:  

Mesh:

Year:  2012        PMID: 22462703     DOI: 10.3171/2011.12.PEDS11124

Source DB:  PubMed          Journal:  J Neurosurg Pediatr        ISSN: 1933-0707            Impact factor:   2.375


  5 in total

Review 1.  Comparison and Selection of Current Implantable Anti-Epileptic Devices.

Authors:  Stephen Wong; Ram Mani; Shabbar Danish
Journal:  Neurotherapeutics       Date:  2019-04       Impact factor: 7.620

2.  Ictal heart rate changes and the effects of vagus nerve stimulation for patients with refractory epilepsy.

Authors:  Wei Chen; Fan-Gang Meng
Journal:  Neuropsychiatr Dis Treat       Date:  2017-09-05       Impact factor: 2.570

3.  Complete section of the left vagus nerve does not preclude the efficacy of vagus nerve stimulation: illustrative case.

Authors:  Alice Noris; Paolo Roncon; Simone Peraio; Anna Zicca; Matteo Lenge; Andrea Di Rita; Lorenzo Genitori; Flavio Giordano
Journal:  J Neurosurg Case Lessons       Date:  2021-07-19

4.  New onset syncopal events following vagus nerve stimulator implantation might be key to preventing vagus nerve stimulation-induced symptomatic bradycardia - A case report and review.

Authors:  Hiroko Kato; Ayataka Fujimoto; Tohru Okanishi; Ryo Sugiura; Kentaro Ijima; Hideo Enoki
Journal:  Epilepsy Behav Case Rep       Date:  2018-04-25

5.  Management and outcome of vagus nerve stimulator implantation: experience of an otolaryngeal/neuropediatric cooperation.

Authors:  S Grasl; S Janik; A Dressler; R Diehm; G Gröppel; K Eichinger; M C Grasl; W Gstoettner; M Feucht; E Vyskocil; W D Baumgartner
Journal:  Eur Arch Otorhinolaryngol       Date:  2021-07-01       Impact factor: 2.503

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.